Status:

COMPLETED

Adult Stem Cell Therapy for Repairing Articular Cartilage in Gonarthrosis

Lead Sponsor:

Banc de Sang i Teixits

Collaborating Sponsors:

Centro Medico Teknon

Institut de Terapia Regenerativa Tissular

Conditions:

Osteoarthritis, Knee

Knee Injuries

Eligibility:

All Genders

18-65 years

Phase:

PHASE1

PHASE2

Brief Summary

This is a prospective, open-label, single-dose, single-arm phase I-II study in which 15 patients diagnosed with gonarthrosis grade II-III (Kellgren and Lawrence) will enter the study with the primary ...

Eligibility Criteria

Inclusion

  • Gonarthrosis grade II-III of Kellgren and Lawrence assessed by two observers
  • Chronic knee pain with mechanical characteristics
  • Absence of local or systemic septic process
  • Haematological and biochemical laboratory tests without significant alterations that contraindicate treatment.
  • Informed Consent form signed by the patient
  • The patient is able to understand the nature of the study

Exclusion

  • Patients \< 18 years or legally dependent
  • Patients \>65 years
  • Previous surgery of the knee
  • Intraarticular treatment in the past 6 month
  • Knee ligament or meniscus rupture observed by MRI
  • Any sign of infection
  • Positive serology for HIV-1 or HIV-2, Hepatitis B (HBsAg), Hepatitis C (Anti-HCV-Ab) and syphilis.
  • Congenital or acquired malformation resulting in significant deformity of the knee and leading to problems in application or evaluation of results.
  • Overweight expressed as body mass index (BMI) greater than 30.5 (obesity grade II). BMI estimated as mass (kg) / corporal surface (m2).
  • Pregnant women or intend to become pregnant or breast-feeding
  • Neoplasia
  • Immunosuppressive states
  • Participation in another clinical trial or treatment with a different investigational product within 30 days prior to inclusion in the study.
  • Other pathologic conditions or circumstances that difficult participation in the study according to medical criteria

Key Trial Info

Start Date :

October 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2013

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT01227694

Start Date

October 1 2010

End Date

January 1 2013

Last Update

December 11 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centro Medico Teknon-ITRT

Barcelona, Spain, 08022